MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Stability Notes

Protect from light.

Provenance

This compatibility recommendation is derived from Zestoretic 20 tablets (Atnahs Pharma UK Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Zestril 10mg tablets (Atnahs Pharma UK Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Zestril 10mg tablets (Atnahs Pharma UK Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Zestril 20mg tablets (Atnahs Pharma UK Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Zestril 20mg tablets (Atnahs Pharma UK Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Zestril 20mg tablets (Atnahs Pharma UK Ltd).

Stability Notes

This compatibility recommendation is derived from Zestril 5mg tablets (Atnahs Pharma UK Ltd).

Provenance

This compatibility recommendation is derived from Zestril 5mg tablets (Atnahs Pharma UK Ltd).

Stability Notes

This compatibility recommendation is derived from Zestril 5mg tablets (Atnahs Pharma UK Ltd).

Provenance

This compatibility recommendation is derived from Zestril 5mg tablets (Atnahs Pharma UK Ltd).

Stability Notes

Should be stored in airtight container. Protect from light

Provenance

This compatibility recommendation is derived from Tildiem 60mg modified-release tablets (Sanofi).

Stability Notes

This medicinal product does not require any special storage conditions.

Provenance

This compatibility recommendation is derived from Diamicron 30mg MR tablets (Servier Laboratories Ltd).

Print this list

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.
Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.
Medicines under this category are not suitable for use inside MCAs.
We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.